Deirdre Celotto

About Deirdre Celotto

Results-oriented senior marketing professional with 15+ years experience consumer marketing and managing brands, categories, products and services within start-ups, mid-sized companies, Fortune 500, and Global companies. Proven ability to lead teams to design and execute high-impact, integrated marketing campaigns leveraging digital and traditional media, B2B and B2C marketing, advertising, promotions, and sales and educational materials to deliver positive ROI across a wide variety of industries including healthcare, biotech, biopharma, consumer goods, entertainment, retail and technology. Exceptional team leader with a passion for leading and supporting team members\' career development goals and paths. Brand evangelist. Brands/companies worked for/with include: Global Blood Therapeutics, Pfizer, Genentech, Amgen, Time Warner, Levi\'s, Kmart, Macy\'s, and JC Penney, among others Specialties include: Brand positioning; Go-to-market, pre-launch and launch initiatives; messaging and content strategy; consumer insight development; integrated campaign development and execution; brand planning; strategic marketing; brand, category and product management; multi-channel marketing; marketing communications; advertising; consumer promotions;B2B and B2C marketing expertise; multicultural marketing.

Experience

1. Dtc Marketing Lead

   Global Blood Therapeutics

   Aug 2022 — Present · South San Francisco, CA, US

   Developed strategy and led implementation of all DTC Go To Market, pre-launch, disease state education and commercial activities to support the accelerated, conditional (Sub Part H) approval of GBT’s first commercial product, Oxbryta, for Sickle Cell Disease in 2019. Oxbryta received an expanded indication for patients as young as 4 years old in 2021, and an additional pediatric formulation was approved in 2022. Led development of messaging and content strategy for Oxbryta branded and unbranded Patient campaigns including the first Oxbryta television commercial that increased awareness (51%) and trial of Oxbryta (49%). Developed strategy and oversaw launch of unbranded disease state education patient campaign (Sickle Cell Speaks) social media campaign, development of disease state education videos (1.6 million views), Patient materials and Sales tools. Patient Marketing lead for 2023 US Brand Planning. GBT acquired by Pfizer in 2022.

Education

• Fordham University School of Law

  Doctor of Law - JD

• Yale University

  BA